申请人:Axys Pharmaceuticals, Inc.
公开号:US06506733B1
公开(公告)日:2003-01-14
Compounds of the formula:
are provided, and are useful as cysteine protease inhibitors, particularly in the treatment of diseases such as osteoporosis or autoimmune disorders in which cathepsins K or S contribute to the pathology or symptomatolgy of the disease.
提供了公式为的化合物,其作为半胱氨酸蛋白酶抑制剂具有用处,特别是在治疗疾病方面,如骨质疏松或自身免疫性疾病,其中猫蛋白酶K或S对疾病的病理学或症状学有贡献。